Breaking News - The Fly

Open Search

MLYS

Mineralys Therapeutics

$

()

Mineralys Therapeutics initiated with bullish view at Goldman Sachs, here's why

MLYS

4/2/2024 - 04:59am

Mineralys Therapeutics initiated with bullish view at LifeSci Capital

MLYS

3/26/2024 - 07:18am

Mineralys Therapeutics files to sell 8.89M shares of common stock for holders

MLYS

3/21/2024 - 07:34am

Mineralys Therapeutics files $500M mixed securities shelf

MLYS

3/21/2024 - 07:34am

Mineralys Therapeutics reports Q4 EPS (61c), consensus (82c)

MLYS

3/21/2024 - 07:07am

Mineralys Therapeutics to sell 8.9M shares at $13.50 in private placement

MLYS

2/8/2024 - 08:13am

Mineralys Therapeutics names Minji Kim, Ph.D. as Chief Business Officer

MLYS

1/4/2024 - 16:15pm

Mineralys Therapeutics doses first subject in Launch-HTN pivotal trial

MLYS

12/21/2023 - 16:20pm

Mineralys Therapeutics reports Q3 EPS (57c), consensus (76c)

MLYS

11/7/2023 - 17:01pm

Mineralys presents post-hoc analysis from Phase 2 trial of lorundrostat

MLYS

11/2/2023 - 10:09am

Mineralys Therapeutics presents Target-HTN Phase 2 trial results

MLYS

9/10/2023 - 07:47am

Four new option listings and one option delisting on August 23rd

ALNT , MLYS , NN

…

8/23/2023 - 08:30am

Mineralys expands lorundrostat trial and with inhibitor combo for CKD treatment

MLYS

7/17/2023 - 16:16pm

Mineralys Therapeutics announces first patient dosed in ADVANCE-HTN trial

MLYS

5/2/2023 - 08:17am